SCN5A Variant V1667I

Summary of observed carriers, functional annotations, and structural context for SCN5A V1667I. Data combine curated literature, international cohorts, and gnomAD observations.

Estimated LQT3 penetrance

24%

4/25 effective observations

Estimated BrS1 penetrance

8%

1/25 effective observations

Total carriers

15

1 BrS1 · 4 LQT3 · 10 unaffected

V1667I is present in 1 alleles in gnomAD. This residue resides in a Non_Hotspot region for Brugada syndrome and a Mild_Hotspot region for LQT3.

Variant features alone are equivalent to phenotyping 0 individuals for Brugada syndrome and 0 individuals for LQT3.

In silico predictors

Variant-level computational predictors.
PROVEAN PolyPhen-2 BLAST-PSSM REVEL Penetrance Density BrS (%) Penetrance Density LQT3 (%)
-0.96 0.986 3.12 0.802 10 19

PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).

Reported carrier data

Observed carriers by publication or cohort.
Source Year Carriers Unaffected LQT3 BrS1 Other Other Disease
11274952 2001 11 2 0 0
15840476 2005 1 1 0 0
15996170 2005 1 0 0 1 VT
19843921 2009 1 0 1 0
20566482 2010 4 4 0 0
20659946 2010 7 7 0 0
27566755 2016 2 2 0 0
20129283 2010 1 0 1 0
Literature, cohort, and gnomAD 15 10 4 1
Variant features alone 15 15 0 0

Totals may differ from individual publications due to duplicate patients removed during curation.

Functional data

Peak and late/persistent current values are relative to wild-type (100% indicates no change). V1/2 activation and inactivation denote the membrane potentials (mV) at which half-maximal current is achieved.

Published electrophysiology measurements.
PubMed ID Year Cell Type Peak Current (% WT) V1/2 Activation (mV) V1/2 Inactivation (mV) Late/Persistent Current (% WT)
11274952 2001
15840476 2005
15996170 2005
19843921 2009
20566482 2010
20659946 2010
27566755 2016
20129283 2010

Nearby variants

Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD.

Previously observed variants near V1667I.
Neighbour residue Distance (Å) Observed variants
1702 14
1328 15 V1328M,
1659 13
1765 14
1304 13 T1304M,
1757 12
1315 14
1216 15 L1216V,
1698 15 A1698T,
1756 12 I1756V,
1314 11 c.3940_3941delCT,
1320 13 M1320I, M1320I, M1320I,
1673 11
1675 12
1764 12 V1764F, c.5290delG,
1666 5
1754 10
1707 11
1694 15
1704 9 L1704H,
1706 14 Q1706H, Q1706H,
1669 7
1671 6
1762 11 I1762M, p.I1762del,
1668 5 M1668T,
1676 14 M1676T, M1676I, M1676I, M1676I,
1219 14 S1219N,
1753 14 T1753A,
1672 9 S1672Y,
1767 14 Y1767C,
1313 14
1660 10 I1660S, I1660V,
1310 11
1766 12 M1766L, M1766T, M1766V, M1766L,
1665 7
1305 14
1703 13
1663 6
1759 8 S1759C,
1662 10
1324 13
1327 12
1709 13 T1709M, p.T1709del, T1709R,
1701 10 M1701I, M1701I, M1701I,
1307 10
1758 7 p.I1758del, I1758V,
1223 14 c.3667delG,
1755 7
1697 14
1674 11 F1674V,
1713 15
1323 13 V1323G,
394 15
1708 9 T1708I,
1705 11
1700 12
1763 9 V1763M, V1763L, V1763L,
1751 11
1311 9 L1311P,
1308 10 L1308F,
1760 13
1752 13
1670 5
1661 9 G1661R, G1661E, G1661R,
1761 13 L1761H, L1761F, c.5280delG,
1710 15 S1710L,
398 14
1667 0 V1667I,
1664 6